Home
>
National Drug Code (NDC)
>
Desferal
Desferal - 0078-0347-51 - (deferoxamine mesylate)
Drug Information of Desferal
| Product NDC: | 0078-0347 |
| Proprietary Name: | Desferal |
| Non Proprietary Name: | deferoxamine mesylate |
| Active Ingredient(s): | 2000 mg/1 & nbsp; deferoxamine mesylate |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Desferal
| Product NDC: | 0078-0347 |
| Labeler Name: | Novartis Pharmaceuticals Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA016267 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19680402 |
Package Information of Desferal
| Package NDC: | 0078-0347-51 |
| Package Description: | 4 VIAL in 1 CARTON (0078-0347-51) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (0078-0347-61) |
NDC Information of Desferal
| NDC Code | 0078-0347-51 |
| Proprietary Name | Desferal |
| Package Description | 4 VIAL in 1 CARTON (0078-0347-51) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (0078-0347-61) |
| Product NDC | 0078-0347 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | deferoxamine mesylate |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Start Marketing Date | 19680402 |
| Marketing Category Name | NDA |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Substance Name | DEFEROXAMINE MESYLATE |
| Strength Number | 2000 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Iron Chelating Activity [MoA],Iron Chelator [EPC] |
